🚀 VC round data is live in beta, check it out!
- Public Comps
- Reckitt
Reckitt Valuation Multiples
Discover revenue and EBITDA valuation multiples for Reckitt and similar public comparables like Haleon, Galderma, Bayer, Kenvue and more.
Reckitt Overview
About Reckitt
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio that includes a variety of household and consumer health brands, such as Lysol, Finish, Durex, and Mucinex, many of which hold a number-one or number-two position in their categories globally. Reckitt has repositioned its portfolio and has entered the infant formula market through the acquisition of Mead Johnson in 2017, expanded its consumer health presence by acquiring Schiff Nutrition, K-Y, and Biofreeze, and has exited the food industry. The firm operates in 60 countries and sells products in more than 200, generating over 35% of sales from emerging markets.
Founded
2007
HQ

Employees
35.1K
Website
Sectors
Financials (LTM)
EV
$53B
Reckitt Financials
Reckitt reported last 12-month revenue of $18B and EBITDA of $5B.
In the same LTM period, Reckitt generated $11B in gross profit, $5B in EBITDA, and $3B in net income.
Revenue (LTM)
Reckitt P&L
In the most recent fiscal year, Reckitt reported revenue of $19B and EBITDA of $6B.
Reckitt expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $18B | XXX | $19B | XXX | XXX | XXX |
| Gross Profit | $11B | XXX | $12B | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 61% | XXX | XXX | XXX |
| EBITDA | $5B | XXX | $6B | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 34% | XXX | XXX | XXX |
| EBIT Margin | 25% | XXX | 25% | XXX | XXX | XXX |
| Net Profit | $3B | XXX | $4B | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 22% | XXX | XXX | XXX |
| Net Debt | — | — | $9B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Reckitt Stock Performance
Reckitt has current market cap of $44B, and enterprise value of $53B.
Market Cap Evolution
Reckitt's stock price is $67.74.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $53B | $44B | 0.0% | XXX | XXX | XXX | $6.70 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialReckitt Valuation Multiples
Reckitt trades at 2.8x EV/Revenue multiple, and 9.7x EV/EBITDA.
EV / Revenue (LTM)
Reckitt Financial Valuation Multiples
As of April 20, 2026, Reckitt has market cap of $44B and EV of $53B.
Equity research analysts estimate Reckitt's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Reckitt has a P/E ratio of 13.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $44B | XXX | $44B | XXX | XXX | XXX |
| EV (current) | $53B | XXX | $53B | XXX | XXX | XXX |
| EV/Revenue | 2.8x | XXX | 2.7x | XXX | XXX | XXX |
| EV/EBITDA | 9.7x | XXX | 8.2x | XXX | XXX | XXX |
| EV/EBIT | 11.4x | XXX | 11.1x | XXX | XXX | XXX |
| EV/Gross Profit | 4.7x | XXX | 4.5x | XXX | XXX | XXX |
| P/E | 13.9x | XXX | 10.1x | XXX | XXX | XXX |
| EV/FCF | 20.7x | XXX | 20.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Reckitt Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Reckitt Margins & Growth Rates
Reckitt's revenue in the last 12 month declined by (5%).
Reckitt's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Reckitt's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Reckitt's rule of X is 4% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Reckitt Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (5%) | XXX | (10%) | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 34% | XXX | XXX | XXX |
| EBITDA Growth | (8%) | XXX | (24%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 4% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 23% | XXX | 25% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 37% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Reckitt Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Reckitt | XXX | XXX | XXX | XXX | XXX | XXX |
| Haleon | XXX | XXX | XXX | XXX | XXX | XXX |
| Galderma | XXX | XXX | XXX | XXX | XXX | XXX |
| Bayer | XXX | XXX | XXX | XXX | XXX | XXX |
| Kenvue | XXX | XXX | XXX | XXX | XXX | XXX |
| Hindustan Unilever | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Reckitt M&A Activity
Reckitt acquired XXX companies to date.
Last acquisition by Reckitt was on XXXXXXXX, XXXXX. Reckitt acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Reckitt
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialReckitt Investment Activity
Reckitt invested in XXX companies to date.
Reckitt made its latest investment on XXXXXXXX, XXXXX. Reckitt invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Reckitt
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Reckitt
| When was Reckitt founded? | Reckitt was founded in 2007. |
| Where is Reckitt headquartered? | Reckitt is headquartered in United Kingdom. |
| How many employees does Reckitt have? | As of today, Reckitt has over 35K employees. |
| Who is the CEO of Reckitt? | Reckitt's CEO is Kris Licht. |
| Is Reckitt publicly listed? | Yes, Reckitt is a public company listed on London Stock Exchange. |
| What is the stock symbol of Reckitt? | Reckitt trades under RKT ticker. |
| When did Reckitt go public? | Reckitt went public in 2007. |
| Who are competitors of Reckitt? | Reckitt main competitors are Haleon, Galderma, Bayer, Kenvue. |
| What is the current market cap of Reckitt? | Reckitt's current market cap is $44B. |
| What is the current revenue of Reckitt? | Reckitt's last 12 months revenue is $18B. |
| What is the current revenue growth of Reckitt? | Reckitt revenue growth (NTM/LTM) is (5%). |
| What is the current EV/Revenue multiple of Reckitt? | Current revenue multiple of Reckitt is 2.8x. |
| Is Reckitt profitable? | Yes, Reckitt is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Reckitt? | Reckitt's last 12 months EBITDA is $5B. |
| What is Reckitt's EBITDA margin? | Reckitt's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Reckitt? | Current EBITDA multiple of Reckitt is 9.7x. |
| What is the current FCF of Reckitt? | Reckitt's last 12 months FCF is $3B. |
| What is Reckitt's FCF margin? | Reckitt's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Reckitt? | Current FCF multiple of Reckitt is 20.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.